Practice Trends
APhA Tops List in BW Education Program PhA once again topped the list of national pharmacy associations selected by pharmacists across the country to receive funds under the Burroughs Wellcome Co. Pharmacy Education (BW) Program. APhA will receive $20,500 of the $78,000 to be awarded under the 1987 BW program to the educational activities of six national pharmacy associations. Representing APhA at the drawings for the 1987 winners held in Research Triangle Park, NC, were Chairman of the Board D. Stephen Crawford and Director of Educational Affairs Samuel R. Kalman. Crawford took the opportunity to express APhA's sincere appreciation to Burroughs Wellcome and to the many pharmacists across the country who selected APhA on their entry forms.
A
ceutical Sciences (JUC PRARM SCI). More than 54,000 entries were re~ ceived this year - truly a testimonial to the interest within the profession in the program. Total BW CatherineB.Alvarez, Providence, RI J.J. Balli" Weslaco, TX Doreen ·M. Beiswanger,* Valley City, ND Beverly Brewer, Luling, TX George B. Browning,* Melbourne, FL Lynn E. Carroll,* Ogden, UT David Chuckta, Bridgeport, Robert R. Cone, Berlin, NH George E. Darlington, * Lander, WY Charles A. Decker,* Anchorage, AK Zoraida DeJesus, Fajardo, PR Terry A. Dennis, Colchester, VT KarenP. Dunavant, * Edgewood, MD Glenn M. Ellsworth, Henderson, NV Michael J. Gaidys, Bethel, VT Gino V. Gangai,* Millbury, MA Kim A. Harris,* Crossett, AR Bernard Keegan, * Lincoln, RI Charlie Loftin, * Mobile, AL Cynthia Lord, Manhattan, KS Jim Lovell, Anadarko, OK
cr
donations to pharmacy schools and associations under the 1987 program will be $161,000 - bringing the total contributions by BW over the past 13 years to $1.64 million. APhA expresses its sincere appreciation to those pharmacists who selected APhA as the association to receive funds under this program: Jo§eph W L.,!~ius, Jr.,* Minneapolzs, MN . Thomas Lynch, Mililani Town, HI Robert J. Metelak, Dubuque, IA Christine M. Miles, *Louisville, KY Tom R. Nash, Anchorage, AK Cynthia Nelson, Las vegas, NV Janet L. Ohrt, * Holdrege, NE Gerand R. Paszkiet,* Chicago, IL Joe G. Price, * Rogersville, TN Rich 'Rassas, Long Beach, NJ Thomas W Reeder,* Marshalltown, fA Libby F. Shapiro, Caldwell, NJ Pamela J. Sharkey, Maple Heights, OH J. Fred Smith, Phoenix, AZ Gary Uithoven, Edgerton, MN James H. Vandiver,* Douglasville, GA Stanley A. Weiss,* Cincinnati, OR Henry Wineglass, * Washington, DC David J. Wunrow, * Marshfield, WI Carol L.-Zikmund, * Columbus, NE
*APhA members.
®
Expiration Dating Guidelines for ·OTC Products Aid Consumers
C
Each year, pharmacists from every state are invited to participate in the program. The money awarded to APhA goes to support the APhA Foundation, which has provided funding for the Community Pharmacy Residency Program, the Impaired Pharmacist Program, the curricular resources for the nontraditional PharmD program, and subsidies for graduate students attending the upcoming Joint JapanUnited States Congress of Pharma14
onsumer alertness about nonprescription product safety has made product expiration dates increasingly important in consumer purchasing decisions, according to a recent survey of health trends (The Pink Sheet, July 13, 1987). Only since passage of the Good Manufacturing Practice regulations that went into effect on September 29, 1978, has expiration dating been required by law. The regulations stipulate that all prescription and most nonprescription drug product containers must have an expiration date, "to assure that a drug
product meets applicable standards of identity, strength, quality -and purity at the time of use." As early as 1970, an APhA Policy Committee recommended that APhA adopt, as policy, recommendations for expiration dating of prescription and nonprescription drugs. In 1971, the APhA House of Delegates adopted as policy the recommendation "that manufacturers of prescription and nonprescription drugs include on the package label adequate information regarding storage requirements and a date after which the product should not
American Phamlacy, -Vol. NS27, No. 11, November 19871738
Practice Trends be used. To simplify product location and recall at all levels of distribution," the recommendation continued, "expiration date should fall in the months of January or July, when feasible (eg, long-dated products)." , With self-care now the largest portion of health care in the country - most Americans use at least one nonprescription medicine every day for such ailments as headaches, allergies, the common cold or flu, athlete's foot, and upset stomach or for oral hygiene and prevention of tooth decay - the Proprietary Association (PA), representing the nonprescription pharmaceuticals industry, has urged its member companies to implement expiration dating improvements according to guidelines adopted at its annual meeting in May. When planning any label revision (text or graphic), PA member companies were requested to consider the following elements, included in P.Ns pamphlet entitled "Guidelines for Expiration Dating of OTe Medicines": • Legibility. The expiration dating should display the information on the package so that the information can be read by the ordinary individual under customary conditions of purchase and use; • Location. The expiration date should not overlap other label copy (eg, bar codes); • Identity statements. These should be easily understood by the consumer (eg, 'Exp6/89,' 'ExpJune 89,' 'Expires 6/89'); • Other packaging features. Consider whether features might interfere with legibility at point of purchase; • Emerging technologies. Consider using technologies such as improved debossing and advances in ink printing to improve expiration dating; • Effective internal controls. Establish methods for assuring the quality of the company's expiration dating program; • Needs of wholesalers, pharmacies, and other retailers for price stickering. Needs that might be addressed include placement of
uct's stability profile and expiration period based on packaging, storage requirements, and ingredient compatibility - has been consumer assurance that products they buy are labeled with accurate expiration dates. ®
the expiration date and lot number near the UPC symbol, or placement of the expiration date and lot number on the bottom endflap. A result of manufacturers' compliance with FDA expiration dating requirements - defining each prod-
State Dispensing Fees for Medicaid
C
ontrary to APhA expectations, the Health Care Financing Administration recently ruled that reimbursement mechanisms and levels for pharmaceutical services provided to Medicaid recipients will be left up to the states, provided they do not exceed maximum payment levels established by the regulation. APhA for several years had urged establishing a unifonn national reimbursement mechanism that would replace the currently "grossly inadequate" compensation
State
to pharmacists for the services and drug products provided to Medicaid recipients. For better understanding. of the wide range of state dispensing fees, we report the 1987 state drug reimbursement fees for Medicaid outpatient programs as of August 12 1987, compiled by the National Pharmaceutical Council, Inc. (Pharmaceutical Benefits Under State Medical Assistance Programs, September 1987). ®
State
Fee
Montana. . . . . . . . . . . . . . . . . . . .. 2.00-3.75 Nebraska 4 .. . .. ... . . . . . . . . 4.66-5.12 Nevada .............. . ..... . , 3.95 New Hampshire. . . . . . . . . . . . . .. 2 .85 New Jersey. . . . . . . . . . . . . .. 3.53-3.87 New Mexico. . . . . . . . . . . . . . . . .. 3.65 New York. . . . . . . . . . . . . . . . . . .. 2 .60 North Carolinas. . . . . . . . . . . . . .. 3.67 North Dakota. . . . . . . . . . . . . . . . . 3.75 Ohio.............. . ......... 3.12 Oklahoma "' ......... . ...... . . 3.55 Oregon .... . ... ~ . . . . . . . . . 3.38-3.68 Pennsylvania. . . . . . . . . . . . . . . . .. 2.75 Rhode Island . .. .............. 3.25 South Carolina. . . . . . . . . . . . . . .. 3.40 South Dakota. . . . . . . . . . . . . . . .. 4.25 Tennessee ... . .. . ... . . . ...... 3.48 Texas 6 . . . . . . . . . . ... . . . . . . . . . . .. Utah. . . . . . . . .. .... . . . . . . . ... 3.75 Vermont. . . . . . . . . . . . . . . . . . . . . 2.75 Virginia . . . . . . . . . . . . . . . . . . . . .. 3.40 Washington ..... ... ..... . 3.00-3.70 West Virginia. . . . . . . . . . . . . . . .. 2.75 Wisconsin ,. . . . . . . . . . . . . . . . . . .. 3.68 Wyoming' .................. . . . -
Alabama ..... ........ . : . ... . .. ... $3.25 Alaska' . ... .' ........ . .. .. .. . ... Arizona 2 . . . . . . . . . . . . . . . . . . . . ' ... Arkansas. . . . . . . . . . . . . . . . . . . .. 4.01 California ....... . ....... . .... 4.05 Colorado .. . . .. . . . . .. . .. . .... 3.78 Connecticue ............... . . 3.55 Delaware 3 . . . . . . . . . . . . . . . . . . .' 3.65 District.of ,Columbia ........... 4.25 Florida . . . . . . . . . . . . . . . . . . . . . .. 4.23 Georgia ........ ... .. .. ... .. . 4.14 Hawaii ... . . . ....... .. ....... . 3.22 Idaho ................... 2.50-3.50 Illinois .......... . ............ 3.47 Indiana .... .. ................ 3.00 lowa 3 .. . .. . . .. . . . . . . . . . . . . . . 5.01 Kansas . ...... . .......... 2.46-4.67 Kentucky ....... . . '. . . . . . . . . . . 3.25 Louisiana ...... . ............. 3.30 Maine. .. ... . . . .. . . . . . . . . . . .. 3.35 Maryland . . . . ................ 3.70 Massachusetts .... . . . . . . . . . .... 3.67 Michigan ... .. . . .... . ........ 3.68 Minnesota . .................. 4.00 Mississippi ....... : . . . . . . . . . . .. 3.33 Missouri ..... ... ....... . .... . 2.75
I
1 2 3
No drug program. AHCCS Capitation Plan . Plus incentive fee for dispensing lower-cost product.
American Phannacy, Vol. NS27, No. 11, November 19871739
Fee
Plus $1 .00 additional when a 30-day supply is dispensed. Per product per month, 6 Amount paid the pharmacy = (EAC + $3.26)/0 .945 .
4
5
15
Practice Trends
New College of Pharmacy on the Scene
J
oining the 73 other colleges dedicated to the advancement ofpharmaceutical science and to the practice of pharmacy is the Southeastern College of Pharmaceutical Sciences in North Miami Beach, FL. The new college of pharmacy addresses the particular ne~ for more phannacists in Florida. According to Southeasterri's president, Morton Terry, ''Florida ranks 45th among the 50 states with a pharmacist-to-population ratio of only 44.7 per 100,000 residents" (American Association of Colleges of Pharmacy News, July/ August 1987). Teny continued, ''This new college of pharmacy will assure a continuous supply of Floridatrained pharmacists and provide an opportunity for area students to be trained closer to home."
Southeastern College of Pharmaceutical Sciences is the first college of pharmacy to be affiliated with an osteopathic medical school, a setting in .which pharmacy students develop a holistic approach to health care. The promise of such an environment, Dean G. Joseph Norwood told American Pharmacy, is that "we will be able to have a student who has a humanistic approach to health care and is able to see the patient as a whole .person." Norwood envisions Southeastern as a place where "the behavioral sciences and the medical sciences corne together," and he emphasizes the college's concern with fostering and strengthening human relations skills and communication skills as means by which pharmacists can
enrich their contributions to public health. In addition to the holistic health care approach, Norwood sees the college exploring new ground in the study of differences in therapeutic 'approaches to patients of different ethnic groups. Demographically, the Miami area lends itself well to such study with its broad ethnic diversity. Of the 50 students in the charter class, selected from 108 applicants and recruited largely from southern Florida, 36 are women, representing one of the highest proportions of women in any pharmacy college in the country. Twenty of the 50 students already have an undergraduate degree, and students may decide after their second year whether they will pursue a3-year BS degree in pharmacy or a 4-year PharmD degree. ®
U.S; Postal Service
Statem-ent of Ownership, Management, and Circulation (Required by 39 U.S.C. 3685) 1.
2. 3.
4. 5. 6.
7. 8. 9.
16
A. Title of puhlication: American Pharmacy B. Publication number: 283660 Date of filing: October 1, 1987 Frequency of issue: Monthly A. Number of issues published annually: 12 B. Annual subscription price: $35 Complete mailing address of known office. of publication: 2215 Constitution A venue, NW, Washington, DC 20037 Complete mailing address of the headquarters or general business offices of the publishers: Same Full names and complete mailing addresses of publisher, editor, and managing editor: Publisher-John F. Schlegel, PharmD, MSEd, President, American Pharmaceutical Association, 2215 Constitution Avenue, NW, Washington, DC 20037; Editor-John Covert, American Pharmacy, 2215 Constitution Avenue, NW, Washington, DC 20037. Owner: American Pharmaceutical Association, 2215 Constitution Avenue, NW, Washington, DC 20037. Known bondholders, mortagees, and other security holders owning or holding 1 percent or more of total amount of bonds, mortgages, or other securities: None For completion by nonprofit organizations authorized to mail at special rates (Section 423.12 DMM only): The purpose, function, and nonprofit status of this organization and the exempt. status for federal income tax purposes has not changed during the preceding 12 months.
10. Extent and nature of circulation:
A. Total no. copies (Net press run) B. Paid and/or requested circulation: 1. Sales through dealers and carriers, street vendors and counter sales 2. Mall subscription (Paid and/or requested) C. Total paid and/or requested circulation (Sum oflOB 1 andlOB2) ·D. Free distribution by mail, carrier or other means-samples, complimentary and other free·copies E. Thtal distribution (Sum ofC and D) F. Copies not distributed: 1. Office use, left over, unaccounted, spoiled after printing 2. Return from news agents G. Total (Sum ofE,Fl and2should equal net press run shown inA)
Average Actual no. copies no. copies each issue of single during issue preceding published 12.months nearest to filing date 38,71935,500 0
0
32,766
34,147
32,766
34,147
735 33,501
825 34,972
5~218
0
528 0
38,719
35,500
11. I certify-that the statements made by me above are correct and comple~e: John Covert,. Editor
American Pharmacy, Vol. NS2'7, No. 11, November 19871740